HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Obesity and progression of chronic renal insufficiency: a Czech long term prospective double-blind randomised multicentre study].

Abstract
Obesity represents one of serious risk factors in chronic renal failure patients (CRF). In three years prospective double-blind randomised multicentre study we monitored 66 patients with advanced chronic renal insufficiency, GFR 24.4-37.3 ml/min (0.41 to 0.62 ml/s) and BMI > or = 30 kg/m2 on long term low-protein diet (0.6 P/kg BW/day) and ACEI + ARB. Thirty four randomly selected patients (group I) were treated with keto amino acids, 32 patients in control group (group II) with placebo. During the study period significant decrease of BMI, proteinuria and slowing in progression of renal failure (C(in)) were found. Significant changes were also noted in parameters of albumin and transferrin (p < 0.02), leucin and WQ (p < 0.01 - p < 0.02), glycaemia and HbA1c (p < 0.02), triglycerides (p < 0.01), leptin and ObRe (p < 0.01) and selected parameters of endothelial dysfunction (ET1, p < 0.02, TGFbeta1, p < 0.02). Significantly also decreased PTH value (p < 0.01). Successful treatment of obesity can significantly improve long term prognosis in CRF patients.
AuthorsV Teplan, O Schück, V Hanzal, J Hajný, M Horácková, M Ryba, I Stanek, S Surel, M Bret, M Stollová, D Sasaková
JournalVnitrni lekarstvi (Vnitr Lek) Vol. 52 Issue 6 Pg. 571-6 (Jun 2006) ISSN: 0042-773X [Print] Czech Republic
Vernacular TitleObezita a progrese chronické renální insuficience: ceská dlouhodobá prospektivní randomizovaná dvojite slepá multicentrická studie.
PMID16871760 (Publication Type: English Abstract, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Amino Acids, Essential
Topics
  • Adult
  • Aged
  • Amino Acids, Essential (administration & dosage)
  • Diet, Protein-Restricted
  • Disease Progression
  • Double-Blind Method
  • Female
  • Humans
  • Kidney Failure, Chronic (complications, diet therapy, metabolism)
  • Male
  • Middle Aged
  • Obesity (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: